Investigation of novel indole-based HIV-1 protease inhibitors using virtual screening and text mining

References

• Agrawal, L., Lu, X., Jin, Q., & Alkhatib, G. (2006). Anti-HIV therapy: Current and future directions. Current Pharmaceutical Design, 12(16), 2031–2055. https://doi.org/10.2174/138161206777442100
   PubMed Web of Science ®Google Scholar
• Bandini, M. (2013). Electrophilicity: ole chemistry” dark-side” of indole. Organic & Biomolecular Chemistry, 11(32), 5206–5212. https://doi.org/10.1039/c3ob40735g
   PubMed Web of Science ®Google Scholar
• Banks, J. L., Beard, H. S., Cao, Y., Cho, A. E., Damm, W., Farid, R., Felts, A. K., Halgren, T. A., Mainz, D. T., Maple, J. R., Murphy, R., Philipp, D. M., Repasky, M. P., Zhang, L. Y., Berne, B. J., Friesner, R. A., Gallicchio, E., & Levy, R. M. (2005). Integrated Modeling Program, Applied Chemical Theory (IMPACT). Journal of Computational Chemistry, 26(16), 1752–1780. https://doi.org/10.1002/jcc.20292
   PubMed Web of Science ®Google Scholar
• Bathula, R., Lanka, G., Muddagoni, N., Dasari, M., Nakkala, S., Bhargavi, M., Somadi, G., Sivan, S. K., & Rajender Potlapally, S. (2020). Identification of potential Aurora kinase-C protein inhibitors: An amalgamation of energy minimization, virtual screening, prime MMGBSA and AutoDock. Journal of Biomolecular Structure & Dynamics, 38(8), 2314–2325. https://doi.org/10.1080/07391102.2019.1630318
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., Gunsteren, W. F. v., & Hermans, J. (1981). Interaction models for water in relation to protein hydration. In Intermolecular Forces: Proceedings of the Fourteenth Jerusalem Symposium on Quantum Chemistry and Biochemistry Held in Jerusalem, Israel, April 13–16, 1981 (pp. 331–342). Springer Netherlands. https://doi.org/10.1007/978-94-015-7658-1_21
   Google Scholar
• Bourinbaiar, A. S. (2009). New developments in drug and vaccine discoveries. Current Pharmaceutical Design, 15(11), 1157–1158. https://doi.org/10.2174/138161209787846810
   PubMed Web of Science ®Google Scholar
• Bozzette, S. A., Ake, C. F., Tam, H. K., Chang, S. W., & Louis, T. A. (2003). Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. The New England Journal of Medicine, 348(8), 702–710. https://doi.org/10.1056/NEJMoa022048
   PubMed Web of Science ®Google Scholar
• Campiani, G., Ramunno, A., Maga, G., Nacci, V., Fattorusso, C., Catalanotti, B., Morelli, E., & Novellino, E. (2002). Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: Past, present, and future perspectives. Current Pharmaceutical Design, 8(8), 615–657. https://doi.org/10.2174/1381612024607207
   PubMed Web of Science ®Google Scholar
• Condra, J. H., Schleif, W. A., Blahy, O. M., Gabryelski, L. J., Graham, D. J., Quintero, J. C., Rhodes, A., Robbins, H. L., Roth, E., & Shivaprakash, M. (1995). Apr). In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature, 374(6522), 569–571. https://doi.org/10.1038/374569a0
   PubMed Web of Science ®Google Scholar
• Cutinho, P. F., Roy, J., Anand, A., Cheluvaraj, R., Murahari, M., & Chimatapu, H. S. V. (2020). Design of metronidazole derivatives and flavonoids as potential non-nucleoside reverse transcriptase inhibitors using combined ligand- and structure-based approaches. Journal of Biomolecular Structure & Dynamics, 38(6), 1626–1648. https://doi.org/10.1080/07391102.2019.1614094
   PubMed Web of Science ®Google Scholar
• Deng, J., Dayam, R., Al-Mawsawi, L. Q., & Neamati, N. (2007). Design of second generation HIV-1 integrase inhibitors. Current Pharmaceutical Design, 13(2), 129–141. https://doi.org/10.2174/138161207779313687
   PubMed Web of Science ®Google Scholar
• Desmond. (2011). version 4.9, Schrodinger, LLC, New York.
   Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. https://doi.org/10.1021/jm0306430
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Gottlinger, H. G., Sodroski, J. G., & Haseltine, W. A. (1989). Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America, 86(15), 5781–5785. https://doi.org/10.1073/pnas.86.15.5781
   PubMed Web of Science ®Google Scholar
• Hoover, W. G. (1985). Canonical dynamics: Equilibrium phase-space distributions. Physical Review. A, General Physics, 31(3), 1695–1697. https://doi.org/10.1103/physreva.31.1695
   PubMedGoogle Scholar
• Hou, T., Wang, J., Li, Y., & Wang, W. (2011). Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. Journal of Chemical Information and Modeling, 51(1), 69–82. https://doi.org/10.1021/ci100275a
   PubMed Web of Science ®Google Scholar
• Hruz, P. W. (2008). HIV protease inhibitors and insulin resistance: Lessons from in-vitro, rodent and healthy human volunteer models. Current Opinion in HIV and Aids, 3(6), 660–665. https://doi.org/10.1097/COH.0b013e3283139134
   PubMed Web of Science ®Google Scholar
• Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all-atom protein loop prediction. Proteins, 55(2), 351–367. https://doi.org/10.1002/prot.10613
   PubMed Web of Science ®Google Scholar
• Kakarala, K. K., Jamil, K., & Devaraji, V. (2014). Structure and putative signaling mechanism of Protease activated receptor 2 (PAR2) – A promising target for breast cancer. Journal of Molecular Graphics & Modelling, 53, 179–199. https://doi.org/10.1016/j.jmgm.2014.07.012
   PubMed Web of Science ®Google Scholar
• Klumpp, K., & Mirzadegan, T. (2006). Recent progress in the design of small molecule inhibitors of HIV RNase H. Current Pharmaceutical Design, 12(15), 1909–1922. https://doi.org/10.2174/138161206776873653
   PubMed Web of Science ®Google Scholar
• Kotler, D. P. (2008). HIV and antiretroviral therapy: Lipid abnormalities and associated cardiovascular risk in HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 49(2), 79–85.
   Google Scholar
• Krallinger, M., & Valencia, A. (2005). Text-mining and information-retrieval services for molecular biology. Genome Biology, 6(7), 224.
   PubMed Web of Science ®Google Scholar
• Kumar, A., Rathi, E., & Kini, S. G. (2020). Identification of potential tumour-associated carbonic anhydrase isozyme IX inhibitors: Atom-based 3D-QSAR modelling, pharmacophore-based virtual screening and molecular docking studies. Journal of Biomolecular Structure and Dynamics 38(7), 2156–2170. https://doi.org/10.1080/07391102.2019.1626285
   PubMed Web of Science ®Google Scholar
• Li, J., Abel, R., Zhu, K., Cao, Y., Zhao, S., & Friesner, R. A. (2011). The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins, 79(10), 2794–2812. https://doi.org/10.1002/prot.23106
   PubMed Web of Science ®Google Scholar
• Louis, J. M., Ishima, R., Torchia, D. A., & Weber, I. T. (2007). HIV-1 protease: Structure, dynamics, and inhibition. Advances in Pharmacology (San Diego, Calif.).), 55, 261–298. https://doi.org/10.1016/S1054-3589(07)55008-8
   PubMedGoogle Scholar
• Lv, Z., Chu, Y., & Wang, Y. (2015). HIV protease inhibitors: A review of molecular selectivity and toxicity. HIV/AIDS (Auckland, N.Z.).), 7, 95–104. https://doi.org/10.2147/HIV.S79956
   PubMedGoogle Scholar
• Ma, Z., & Tuckerman, M. (2010). Constant pressure ab initio molecular dynamics with discrete variable representation basis sets. The Journal of Chemical Physics, 133(18), 184110. https://doi.org/10.1063/1.3499812
   PubMed Web of Science ®Google Scholar
• MarvinSketch 18.30.0, chemaxon. (2018).
   Google Scholar
• Matthews, B. W. (1975). Comparison of the predicted and observed secondary structure of T4 phage lysozyme. Biochimica et Biophysica Acta, 405(2), 442–451. https://doi.org/10.1016/0005-2795(75)90109-9
   PubMed Web of Science ®Google Scholar
• Menendez-Arias, L., Matamoros, T., & Cases-Gonzalez, C. E. (2006). Insertions and deletions in HIV-1 reverse transcriptase: Consequences for drug resistance and viral fitness. Current Pharmaceutical Design, 12(15), 1811–1825. https://doi.org/10.2174/138161206776873608
   PubMed Web of Science ®Google Scholar
• N. C. for. HIV/AIDS. (2019). Estimated HIV incidence and prevalence in the United States, 2010–2016. (Vol. 24, Tech. Rep.). Center for Desease Control and Prevetion.
   Google Scholar
• Panda, S. K., Saxena, S., & Guruprasad, L. (2020). Homology modeling, docking and structure-based virtual screening for new inhibitor identification of Klebsiella pneumoniae heptosyltransferase-III. Journal of Biomolecular Structure & Dynamics, 38(7), 1887–1902. https://doi.org/10.1080/07391102.2019.1624296
   PubMed Web of Science ®Google Scholar
• Protein Preparation. (2011). Version 2.5, Schrodinger, LLC, New York.
   Google Scholar
• Raha, K., & Merz, K. M. (2004). A quantum mechanics-based scoring function: Study of zinc ion-mediated ligand binding. Journal of the American Chemical Society, 126(4), 1020–1021. https://doi.org/10.1021/ja038496i
   PubMed Web of Science ®Google Scholar
• Rather, M. A., Dutta, S., Guttula, P. K., Dhandare, B. C., Yusufzai, S. I., & Zafar, M. I. (2020). Structural analysis, molecular docking and molecular dynamics simulations of G-protein-coupled receptor (kisspeptin) in fish. Journal of Biomolecular Structure & Dynamics, 38(8), 2422–2439. https://doi.org/10.1080/07391102.2019.1633407
   PubMed Web of Science ®Google Scholar
• Roy, S., Kumar, A., Baig, M. H., Masařík, M., & Provazník, I. (2015). Virtual screening, ADMET profiling, molecular docking and dynamics approaches to search for potent selective natural molecules based inhibitors against metallothionein-III to study Alzheimer's disease. Methods (San Diego, Calif.).), 83, 105–110. https://doi.org/10.1016/j.ymeth.2015.04.021
   PubMed Web of Science ®Google Scholar
• Sahin, K. S., D. (2020). Identifying new piperazine-based PARP1 inhibitors using text mining and integrated molecular modeling approaches. Journal of Biomolecular Structure and Dynamics, https://doi.org/10.1080/07391102.2020.1715262.
   Google Scholar
• Sahin, K., Zengin Kurt, B., Sonmez, F., & Durdagi, S. (2019). Novel AChE and BChE inhibitors using combined virtual screening, text mining and in vitro binding assays. Journal of Biomolecular Structure and Dynamics, 1–17. https://doi.org/10.1080/07391102.2019.1660218
   Google Scholar
• Saikia, S., & Bordoloi, M. (2019). Molecular docking: Challenges, advances and its use in drug discovery perspective. Current Drug Targets, 20(5), 501–521. https://doi.org/10.2174/1389450119666181022153016
   PubMed Web of Science ®Google Scholar
• Sastry, G. M., Dixon, S. L., & Sherman, W. (2011). Rapid shape-based ligand alignment and virtual screening method based on atom/feature-pair similarities and volume overlap scoring. Journal of Chemical Information and Modeling, 51(10), 2455–2466. https://doi.org/10.1021/ci2002704
   PubMed Web of Science ®Google Scholar
• Shelley, J. C., Cholleti, A., Frye, L. L., Greenwood, J. R., Timlin, M. R., & Uchimaya, M. (2007). Epik: A software program for pK(a) prediction and protonation state generation for drug-like molecules. Journal of Computer-Aided Molecular Design, 21(12), 681–691. https://doi.org/10.1007/s10822-007-9133-z
   PubMed Web of Science ®Google Scholar
• Shen, C. H., Wang, Y. F., Kovalevsky, A. Y., Harrison, R. W., & Weber, I. T. (2010). Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters. The FEBS Journal, 277(18), 3699–3714. https://doi.org/10.1111/j.1742-4658.2010.07771.x
   PubMed Web of Science ®Google Scholar
• Śledź, P., & Caflisch, A. (2018). Protein structure-based drug design: From docking to molecular dynamics. Current Opinion in Structural Biology, 48, 93–102. https://doi.org/10.1016/j.sbi.2017.10.010
   PubMed Web of Science ®Google Scholar
• Soontornniyomkij, V., Umlauf, A., Chung, S. A., Cochran, M. L., Soontornniyomkij, B., Gouaux, B., Toperoff, W., Moore, D. J., Masliah, E., Ellis, R. J., Grant, I., & Achim, C. L. (2014). HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS (London, England)), 28(9), 1297–1306. https://doi.org/10.1097/QAD.0000000000000262
   Web of Science ®Google Scholar
• Subhani, S., Jayaraman, A., & Jamil, K. (2015). Homology modelling and molecular docking of MDR1 with chemotherapeutic agents in non-small cell lung cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 71, 37–45. https://doi.org/10.1016/j.biopha.2015.02.009
   PubMed Web of Science ®Google Scholar
• Taber, D. F., & Tirunahari, P. K. (2011). Indole synthesis: A review and proposed classification. Tetrahedron, 67(38), 7195–7210. https://doi.org/10.1016/j.tet.2011.06.040
   PubMed Web of Science ®Google Scholar
• Todeschini, R., Ballabio, D., & Grisoni, F. (2016). 10). Beware of Unreliable Q2! A Comparative Study of Regression Metrics for Predictivity Assessment of QSAR Models. Journal of Chemical Information and Modeling, 56(10), 1905–1913. https://doi.org/10.1021/acs.jcim.6b00277
   PubMed Web of Science ®Google Scholar
• Tozser, J. (2001). HIV inhibitors: Problems and reality. Annals of the New York Academy of Sciences, 946, 145–159.
   PubMed Web of Science ®Google Scholar
• Tripathi, S. K., Muttineni, R., & Singh, S. K. (2013). Extra precision docking, free energy calculation and molecular dynamics simulation studies of CDK2 inhibitors. Journal of Theoretical Biology, 334, 87–100. https://doi.org/10.1016/j.jtbi.2013.05.014
   PubMed Web of Science ®Google Scholar
• Walker, B. D., & Burton, D. R. (2008). Toward an AIDS vaccine. Science (New York, N.Y.).), 320(5877), 760–764. https://doi.org/10.1126/science.1152622
   PubMed Web of Science ®Google Scholar
• Wlodawer, A., & Erickson, J. W. (1993). Structure-based inhibitors of HIV-1 protease. Annual Review of Biochemistry, 62, 543–585. https://doi.org/10.1146/annurev.bi.62.070193.002551
   PubMed Web of Science ®Google Scholar
• Yeung, K.-S., Qiu, Z., Yin, Z., Trehan, A., Fang, H., Pearce, B., Yang, Z., Zadjura, L., D'Arienzo, C. J., Riccardi, K., Shi, P.-Y., Spicer, T. P., Gong, Y.-F., Browning, M. R., Hansel, S., Santone, K., Barker, J., Coulter, T., Lin, P.-F., Meanwell, N. A., & Kadow, J. F. (2013). Inhibitors of HIV-1 attachment. Part 8: The effect of C7-heteroaryl substitution on the potency, and in vitro and in vivo profiles of indole-based inhibitors. Bioorganic & Medicinal Chemistry Letters, 23(1), 203–208. https://doi.org/10.1016/j.bmcl.2012.10.117
   PubMed Web of Science ®Google Scholar
• Zhang, M. Z., Chen, Q., & Yang, G. F. (2015). A review on recent developments of indole-containing antiviral agents. European Journal of Medicinal Chemistry, 89, 421–441. https://doi.org/10.1016/j.ejmech.2014.10.065
   PubMed Web of Science ®Google Scholar
• Zhao, F., Wang, J.-L., Ming, H.-Y., Zhang, Y.-N., Dun, Y.-Q., Zhang, J.-H., & Song, Y.-B. (2020). Insights into the binding mode and functional components of the analgesic-antitumour peptide from Buthus martensii Karsch to human voltage-gated sodium channel 1.7 based on dynamic simulation analysis. Journal of Biomolecular Structure & Dynamics, 38(6), 1868–1879. https://doi.org/10.1080/07391102.2019.1620126
   PubMed Web of Science ®Google Scholar